Taysha Gene Therapies (TSHA) P/E (2020 - 2026)
Taysha Gene Therapies (TSHA) P/E from Sep 30, 2020 to Jun 3, 2026. The TTM Taysha Gene Therapies (TSHA) P/E is -11.98. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Taysha Gene Therapies (TSHA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -11.98 | -8.37% |
| 2025 | -13.07 | +239.07% |
| 2024 | -3.86 | +369.84% |
| 2023 | -0.82 | +48.61% |
| 2022 | -0.55 | -78.41% |
| 2021 | -2.56 | -91.49% |
| 2020 | -30.04 | N/A |
Comparison Taysha Gene Therapies (TSHA) P/E with competitors
Taysha Gene Therapies (TSHA) P/E is -11.98.